Form EFFECT Can-Fite BioPharma Ltd.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 31, 2026 |
| Accession Number: | 0001213900-26-036574 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Can-Fite BioPharma (CANF) PT Raised to $8 at H.C. Wainwright
- Ilene Beth Miller, M.S. Announces Expanded Holistic Coaching Practice Focused on Personalized Mind, Body, and Wellness Support
- From Ancient Capital to New Digital Silk Road Hub: The 7th Western Digital Economy Expo Sees Xi'an's Industrial Integration Unleash Strong Momentum
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share